Abstract
Over the past years, intracoronary imaging techniques have progressively evolved and growing evidence from observational studies, randomized controlled trials (RCTs) and meta-analyses support their use in order to achieve better procedural results and to improve clinical outcomes. The results of two important trials have been recently presented, adding strong evidence concerning the use of intravascular ultrasound (IVUS) guidance during drug-eluting stent (DES) implantation (ULTIMATE trial), and the role of near-infrared spectroscopy (NIRS) imaging as a tool to identify both patients and coronary plaques at high risk for future events (LIPID RICH PLAQUE study).